Literature DB >> 8385936

Phosphorylation of human topoisomerase I by protein kinase C in vitro and in phorbol 12-myristate 13-acetate-activated HL-60 promyelocytic leukaemia cells.

E Cardellini1, E Durban.   

Abstract

Topoisomerase I was phosphorylated in vitro by protein kinase C (PKC) purified from rat brain with high affinity (Km about 0.1 microM). Tryptic phosphopeptide mapping indicated that two major topoisomerase I peptides phosphorylated in vivo were comigrating with minor peptides phosphorylated by PKC in vitro. Topoisomerase I phosphorylation was stimulated 3-fold in HL-60 cells exposed to the tumour promoter phorbol 12-myristate 13-acetate. The results suggest that topoisomerase I phosphorylation in HL-60 cells is indirectly controlled by PKC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385936      PMCID: PMC1132517          DOI: 10.1042/bj2910303

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

Review 1.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Phosphorylation of purified Novikoff hepatoma topoisomerase I.

Authors:  E Durban; J S Mills; D Roll; H Busch
Journal:  Biochem Biophys Res Commun       Date:  1983-03-29       Impact factor: 3.575

4.  Purification of a protein kinase from human Namalwa cells that phosphorylates topoisomerase I.

Authors:  J S Mills; H Busch; E Durban
Journal:  Biochem Biophys Res Commun       Date:  1982-12-31       Impact factor: 3.575

5.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  Calcium-activated, phospholipid-dependent protein kinase from rat brain. Subcellular distribution, purification, and properties.

Authors:  U Kikkawa; Y Takai; R Minakuchi; S Inohara; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

7.  Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.

Authors:  R Gallagher; S Collins; J Trujillo; K McCredie; M Ahearn; S Tsai; R Metzgar; G Aulakh; R Ting; F Ruscetti; R Gallo
Journal:  Blood       Date:  1979-09       Impact factor: 22.113

8.  Purification and characterization of a nuclear DNA-binding phosphoprotein in fetal and tumor tissues.

Authors:  E Durban; D Roll; G Beckner; H Busch
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

9.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.

Authors:  M Castagna; Y Takai; K Kaibuchi; K Sano; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

10.  DNA topoisomerase I phosphorylation in murine fibroblasts treated with 12-O-tetradecanoylphorbol-13-acetate and in vitro by protein kinase.

Authors:  D S Samuels; N Shimizu
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

View more
  5 in total

1.  Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines.

Authors:  Keya Bandyopadhyay; Ruth A Gjerset
Journal:  Biochemistry       Date:  2011-01-12       Impact factor: 3.162

2.  Phosphorylation of serine residues in the N-terminal domains of eukaryotic type I topoisomerases.

Authors:  K Staron; D S Samuels
Journal:  Mol Biol Rep       Date:  1998-07       Impact factor: 2.316

3.  Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I.

Authors:  Jennifer S Hackbarth; Marina Galvez-Peralta; Nga T Dai; David A Loegering; Kevin L Peterson; Xue W Meng; Larry M Karnitz; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

4.  The predominant form of mammalian DNA topoisomerase I in vivo has a molecular mass of 100 kDa.

Authors:  D S Samuels; N Shimizu
Journal:  Mol Biol Rep       Date:  1994-03       Impact factor: 2.316

5.  Decreased camptothecin sensitivity of the stem-cell-like fraction of Caco2 cells correlates with an altered phosphorylation pattern of topoisomerase I.

Authors:  Amit Roy; Cinzia Tesauro; Rikke Frøhlich; Marianne S Hede; Maria J Nielsen; Eigil Kjeldsen; Bjarne Bonven; Magnus Stougaard; Irina Gromova; Birgitta R Knudsen
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.